Nature Communications (Apr 2022)
Construction of emissive ruthenium(II) metallacycle over 1000 nm wavelength for in vivo biomedical applications
Abstract
Ruthenium (Ru(II)) compounds are of interest as platinum drug replacements but have suffered from suboptimal therapeutic efficiency. Here, the authors design a Ru(II) metallacycle with NIR excitation and emission wavelengths and demonstrate application for deep tumour imaging and chemo-photo therapy.